Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0518779A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sirna Therapeutics Inc
Original Assignee
Sirna Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/205,309external-prioritypatent/US20030190635A1/en
Application filed by Sirna Therapeutics IncfiledCriticalSirna Therapeutics Inc
Publication of GB0518779D0publicationCriticalpatent/GB0518779D0/en
GB0518779A2002-02-202005-09-14RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)
CeasedGB0518779D0
(en)